Altimmune, Inc. (ALT) Net income 2016–2025
Altimmune, Inc. (ALT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$88.1MFY2025 · since FY2016: -$11.1M → -$88.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.1M | +7.3% |
| FY2024 | -$95.1M | -7.5% |
| FY2023 | -$88.4M | -4.4% |
| FY2022 | -$84.7M | +12.7% |
| FY2021 | -$97.1M | -98.0% |
| FY2020 | -$49.0M | -139.0% |
| FY2019 | -$20.5M | +47.6% |
| FY2018 | -$39.2M | +15.6% |
| FY2017 | -$46.4M | -318.7% |
| FY2016 | -$11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice